Last update 08 May 2025

Mixed Protamine Human Insulin(30R) (BIOTON)

Overview

Basic Info

Drug Type
Hormone
Synonyms
Mixed Protamine Human Insulin, SciLin M30, 重和林 M30
Target
INSR
Action
agonists
Mechanism
INSR agonists(Insulin receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus
Inactive Indication-
Originator Organization
BIOTON SABIOTON SA
Active Organization
BIOTON SABIOTON SA
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Mixed Protamine Human Insulin(30R) (BIOTON)
NCT01588639
/ CompletedNot Applicable
A Prospective Multi-centre, Non-randomized, Open-label, Non-interventional Study to Evaluate the Safety, Efficacy and Injection Compliance of Scilin N, Scilin R or Scilin M30 in Chinese Type 2 Diabetes Mellitus (T2DM)
100 Clinical Results associated with Mixed Protamine Human Insulin(30R) (BIOTON)
Login to view more data
100 Translational Medicine associated with Mixed Protamine Human Insulin(30R) (BIOTON)
Login to view more data
100 Patents (Medical) associated with Mixed Protamine Human Insulin(30R) (BIOTON)
Login to view more data
100 Deals associated with Mixed Protamine Human Insulin(30R) (BIOTON)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus
China
BIOTON SABIOTON SA
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free